The rule is short. Only urine and oral fluid count for a DOT drug test. Pick the method you were offered, say whether you are a driver or an employer, plus pick the test reason. The checker gives the verdict, the checks, plus what to do next. If the method is not DOT approved, it tells you what test still has to happen.
Every answer updates the result as you change each field.
Tick the box if a vendor, a collector, or an employer claimed DOT approval for the method. The checker tests the claim against section 40.210.
No. Hair follicle testing is not DOT approved.
Hair: not authorized for any DOT drug test.
Section 40.210 says it plainly: hair testing is not authorized. A hair test cannot satisfy a DOT drug test. A positive hair result cannot be reported to the Drug and Alcohol Clearinghouse. It carries no federal consequences. The driver still needs a DOT urine test for the test reason that applies.
The checks
| Check | Result | Detail |
|---|---|---|
| DOT specimen | Not authorized | Section 40.210 names hair testing as not authorized for DOT drug tests. |
| HHS-certified laboratory | No certification | HHS has not issued final hair testing guidelines, so no laboratory is HHS-certified for DOT hair testing. |
| Split specimen | No Part 40 right | The 72-hour split specimen right in section 40.171 applies to DOT urine and oral fluid tests only. |
| MRO verification | No | No MRO review applies under Part 40 to a hair result. |
| Clearinghouse | Not reportable | A positive hair result cannot be reported to the Clearinghouse. H.R. 4320 would change that, but it is not law. |
The method facts
| Fact | Value | Note |
|---|---|---|
| DOT status | Not authorized | Hair testing is outside the DOT program until HHS issues final guidelines plus DOT amends Part 40. |
| Detection window | About 90 days | Industry figure for 1.5 inches of hair. The 2020 federal proposal used 30 to 60 days for 0.5 to 1.0 inch. |
| Collection | Hair sample | Hair cut close to the scalp, sent to a laboratory. Drugs do not appear in hair for 5 to 7 days after use. |
| Laboratory | No HHS certification | Company hair tests use commercial laboratories. None is HHS-certified for DOT hair testing. |
| What a positive means | Policy consequences only | The employer may act under company policy. No Clearinghouse entry, no SAP process, no CDL downgrade. |
What to do
- You cannot refuse the DOT urine test because you already took a hair test. The hair test does not count.
- Ask whether the hair test is a DOT test or a company policy test. Only a DOT urine test carries federal consequences.
- A positive company hair test cannot be reported to the Clearinghouse, but the employer may still act under company policy.
Notes
- H.R. 4320, a bill in the House, would require carriers to report positive hair results from pre-employment and random tests to the Clearinghouse. It is pending legislation, not law. It has had no action since July 11, 2025.
- The 2020 federal hair proposal would have allowed hair only for pre-employment testing. Even that limited use is not final, so hair cannot satisfy a DOT pre-employment test today.
This tool applies 49 CFR 40.210, 40.67, 40.82, 40.85, plus 40.193 to your inputs. Confirm the result against your company drug and alcohol policy plus your service agent before acting. Detection windows in the table are approximate industry figures, not regulatory figures.
Your inputs stay in this browser. Nothing is sent to our servers. There is no account to create.
Quick answer: No, hair follicle testing is not DOT approved. Under 49 CFR 40.210, only urine and oral fluid specimens screened and confirmed at HHS-certified laboratories are allowed for DOT drug tests. Hair testing, point-of-collection tests, plus instant tests are not authorized. Oral fluid is authorized in the rule but cannot be used yet, because zero HHS-certified oral fluid laboratories exist as of November 2, 2026. Urine is the only method that works for a DOT drug test today. Pick a method above to check what it means for a driver or an employer.
Is hair follicle testing DOT approved?
No. Hair follicle testing is not DOT approved. It never has been. Section 40.210 of 49 CFR Part 40 says it in one sentence: only urine and oral fluid specimens screened and confirmed at HHS-certified laboratories are allowed for drug testing under this part. The same section then names what is not allowed: point-of-collection urine, point-of-collection oral fluid drug testing, hair testing, or instant tests are not authorized. There is no exception for pre-employment testing, no exception for random testing, plus no exception for a carrier that prefers hair.
That surprises drivers, because hair testing is everywhere in trucking hiring. Many large carriers run a hair test on every applicant. The hair test looks back about 90 days, far longer than urine, so it catches drug use a urine test misses. Carriers like it for exactly that reason. But the hair test those carriers run is a company policy test, not a DOT test. It runs beside the DOT urine test, never instead of it. A driver who passes the hair test still takes the DOT urine test. A driver who fails the hair test still takes the DOT urine test.
The distinction matters because the two tests carry different consequences. A verified positive DOT urine test goes to the Drug and Alcohol Clearinghouse, triggers a Substance Abuse Professional evaluation, plus starts the return-to-duty process that ends with a CDL downgrade until the driver completes it. A positive company hair test does none of those things. It cannot be reported to the Clearinghouse. It cannot trigger a SAP evaluation under Part 382, plus it cannot downgrade a CDL. The employer may still act under company policy, which can mean losing the job offer or the job. But the federal consequences need a DOT result.
Drivers facing a hair test should ask one question before the sample is cut: is this a DOT test or a company policy test? The answer changes everything about what happens next. If it is a DOT test, it must be urine, because urine is the only method that works today. If it is a company hair test, the driver still owes the DOT urine test for the same hiring decision. The DOT Drug Test Rights Checker covers what happens at the collection itself, including the split specimen, the shy bladder procedure, plus what counts as a refusal.
What drug test methods does DOT authorize?
Only two methods. Section 40.210 authorizes urine specimens plus oral fluid specimens, each screened and confirmed at an HHS-certified laboratory. The employer picks one or the other at the start of the testing event. The rule is explicit that the employer cannot collect both at the beginning of a test. If the first specimen fails, for example an insufficient urine sample, the collector may switch to the other type under section 40.193, as the employer instructs. That switch is covered below.
The laboratory requirement is as strict as the specimen list. A DOT specimen must be screened and confirmed at a laboratory certified by the Department of Health and Human Services under the National Laboratory Certification Program. HHS publishes the certified list monthly in the Federal Register. A laboratory that is not on that list cannot test a DOT specimen, whatever its other accreditations. The same rule bars instrumented initial testing facilities from DOT work: DOT does not allow IITFs to test DOT-regulated specimens.
The list of banned methods is just as clear. Point-of-collection urine testing, point-of-collection oral fluid testing, hair testing, plus instant tests are not authorized. Blood is not on the authorized list either. Part 40 has no blood drug test procedure at all. A vendor that sells a DOT-approved hair test, a DOT-approved instant cup, or a DOT-approved blood panel is selling something the regulation does not allow. Ask the vendor to name the Part 40 section that authorizes the method. For every banned method, there is none.
| Method | DOT status | What it means |
|---|---|---|
| Urine | Authorized, in use | The standard. Every DOT drug test today is a urine test. |
| Oral fluid | Authorized, not usable | Zero HHS-certified laboratories as of November 2, 2026. |
| Hair follicle | Not authorized | Company policy test only. No Clearinghouse effect. |
| Instant or point-of-collection | Not authorized | No laboratory, no MRO, no DOT result. |
| Blood | Not authorized | No Part 40 procedure exists for blood drug testing. |
The table is the whole answer to the question this page exists for. Everything else on the page explains why the table looks the way it does, plus what to do when the method in front of you is not on the authorized list. Employers building a testing program should start with the urine test, then read the pre-employment rules in the Pre-Employment Hiring Compliance Checker, which covers the queries plus the checks that must happen before a driver starts safety-sensitive work.
Why is oral fluid testing not available yet?
Because the laboratories do not exist yet. DOT authorized oral fluid testing on June 1, 2023, in a final rule published May 2, 2023, at 88 FR 27596. The rule gave employers a choice: urine or oral fluid, with oral fluid collected in front of the collector, which makes cheating far harder. But the rule also set a condition. Before any employer may use oral fluid testing, HHS must certify at least two oral fluid laboratories. One laboratory tests the primary specimen. A different laboratory must be available to test the split specimen if the driver requests it. That second laboratory is the reason the method waits.
Three years later, the count is still zero. HHS publishes the certified laboratory list every month in the Federal Register. The list published November 2, 2026, FR Doc. 2026-22321, says it plainly: at this time, there are no laboratories certified to conduct drug and specimen validity tests on oral fluid specimens. The September 30, 2026 list said the same, as did the June 1, 2026 list. The DOT Office of Drug and Alcohol Policy and Compliance keeps its own page of certified oral fluid laboratories. It lists none.
Two federal moves in October 2026 brought the method closer without making it usable. On October 6, 2026, the Food and Drug Administration issued a final order exempting certain clinical toxicology test systems from premarket notification, which removed a barrier for the testing devices. On October 29, 2026, HHS proposed revisions to the oral fluid Mandatory Guidelines, FR Doc. 2026-22121, which would clarify that a laboratory can certify for split specimen testing only. It would also update collection and laboratory procedures. Comments on that proposal close December 28, 2026. Neither move certifies a laboratory. Until two laboratories certify, oral fluid testing stays authorized on paper plus unavailable in practice.
When the second laboratory does certify, the change will not be instant. Section 40.67(g)(6) gives employers an 18-month grace period from the HHS notification, during which directly observed urine collections may continue while employers set up oral fluid testing. DOT will publish a Federal Register notice stating when the period begins plus when it ends. One catch applies during the grace period: an employer that has decided to use oral fluid testing, plus is ready to do so, must do so. The grace period protects employers that are not ready. It does not excuse an employer that is ready but prefers urine for the directly observed cases.
| Date | What happened |
|---|---|
| June 1, 2023 | DOT authorizes oral fluid testing, 88 FR 27596. Two certified labs required. |
| December 9, 2024 | DOT proposes directly observed urine collections while oral fluid is unavailable, 89 FR 97579. |
| June 10, 2026 | Interim rule takes effect, 91 FR 25507. Directly observed urine where oral fluid is required but unavailable. |
| October 6, 2026 | FDA exempts certain toxicology test systems from premarket notification. |
| October 29, 2026 | HHS proposes oral fluid guideline revisions, FR Doc. 2026-22121. Comments due December 28, 2026. |
| November 2, 2026 | Latest HHS lab list: zero certified oral fluid laboratories. |
What happens when a directly observed collection is required?
Some DOT drug tests must be directly observed. Return-to-duty tests plus follow-up tests are directly observed. A collection is also directly observed when the original specimen was invalid without an adequate medical explanation, or when the collector has reason to believe the driver tampered with the specimen. In a directly observed urine collection, an observer of the same sex as the driver watches the urine leave the body. The observer need not be a qualified collector.
The May 2023 oral fluid rule created a problem here. It required the directly observed collection to be an oral fluid test in the situations where an observer cannot easily be provided, because an oral fluid collection is observed by nature: it happens in front of the collector. But with zero certified oral fluid laboratories, that requirement was impossible to meet. The interim rule effective June 10, 2026, 91 FR 25507, fixed it. Section 40.67(g)(3) now says that when oral fluid testing is not yet available and no same sex observer is present at the collection site, the collector must contact the designated employer representative. The DER either arranges a same sex observer or sends the driver to a collection site acceptable to the employer for a directly observed urine collection.
Once oral fluid testing is available, the rule flips. Section 40.67(g)(4) requires an oral fluid collection when a same sex observer cannot be found for a directly observed urine collection. If the employer has a standing order allowing oral fluid in that situation, the collector follows it. If there is no standing order, the collector contacts the DER, who directs an oral fluid test at the site if the site can do it, or sends the driver to a site that can. Employers should write the standing order now, before the laboratories certify, so collectors know what to do on the day oral fluid becomes real.
Can an employer switch from urine to oral fluid during a collection?
Yes, in one situation: an insufficient specimen. Section 40.193(a) says that when a driver does not provide enough specimen for a drug test, the collector must give the driver another opportunity. As the employer instructs, that second chance can use the same specimen type or an alternate type. A urine collection that fails can become an oral fluid collection, or an oral fluid collection that fails can become a urine collection. The collector discards the insufficient specimen plus its custody and control form, then starts a new collection with a new form, with a notation in the remarks section.
The amounts matter. A sufficient urine specimen is 45 mL in a single void. A sufficient oral fluid specimen is 2 mL in a single sampling. When the driver cannot produce enough urine, the collector urges the driver to drink up to 40 ounces of fluid, spread over up to 3 hours, until the driver produces a sufficient specimen. When the driver cannot produce enough oral fluid, the collector waits 15 minutes, then urges up to 8 ounces of fluid plus 10 more minutes, for up to 1 hour in total. A driver who simply needs more time is not required to drink during the wait.
In practice, the switch to oral fluid is theoretical today, because no certified oral fluid laboratory exists to receive the specimen. The switch that works today runs the other way: an oral fluid collection that cannot be completed becomes a urine collection, which is the only specimen type a laboratory can test. Employers should still write the instruction for both directions, so the collector never has to guess. The instruction belongs in the standing orders given to the collection site, beside the directly observed collection order. A reasonable suspicion test that reaches the collection site late raises its own timing questions, covered in the Reasonable Suspicion Testing Checker.
What drugs does a DOT test check for?
Five classes, no more. Section 40.82 requires the laboratory to test every DOT specimen for marijuana metabolites, cocaine metabolites, amphetamines, opioids, plus phencyclidine, known as PCP. The same section forbids anything else: the laboratory must not test DOT specimens for any other drugs. A carrier that wants to screen for benzodiazepines, barbiturates, or any other substance must run a separate non-DOT test under company policy. The DOT specimen cannot carry it.
Each class has a cutoff: a concentration the laboratory must find before it reports a positive. Testing runs in two stages. The initial screen uses an immunoassay at the higher cutoff. A specimen at or above that cutoff goes to a confirmation test at the lower cutoff, using a precise method such as gas chromatography-mass spectrometry. Only a result that clears both stages is reported as a confirmed positive. A specimen below either cutoff is reported negative, even when trace amounts are present.
| Analyte | Initial screen (ng/mL) | Confirmation (ng/mL) |
|---|---|---|
| Marijuana metabolite (THCA) | 50 | 15 |
| Cocaine metabolite (benzoylecgonine) | 150 | 100 |
| Codeine / morphine | 2,000 | 2,000 |
| Hydrocodone / hydromorphone | 300 | 100 |
| Oxycodone / oxymorphone | 100 | 100 |
| 6-acetylmorphine (heroin marker) | 10 | 10 |
| Amphetamine / methamphetamine | 500 | 250 |
| MDMA / MDA | 500 | 250 |
| PCP | 25 | 25 |
Two details in the table catch people out. The laboratory must report quantitative values for morphine or codeine at 15,000 ng/mL or above, per section 40.85(d). Fentanyl is not on the panel either. DOT proposed adding fentanyl in September 2025, but the proposal is not final as of November 2026, so a DOT test does not check for it. Marijuana rescheduling did not change the panel either: a state medical marijuana card cannot excuse a positive DOT test. Oral fluid cutoffs are lower than urine cutoffs, because concentrations in saliva run lower: the marijuana initial cutoff is 4 ng/mL in oral fluid, against 50 ng/mL in urine, with a 2 ng/mL confirmation.
The panel is the same for every DOT test reason: pre-employment, random, post-accident, reasonable suspicion, return to duty, plus follow-up. The reason changes the timing plus the paperwork, never the panel. Random testing rates are set separately each year: the Random Testing Rate Calculator works out how many random tests the current rates require across the driver pool.
Can a company hair test cost a driver the CDL?
Not by itself. A CDL downgrade follows a Clearinghouse entry. A Clearinghouse entry follows a verified positive DOT test, an alcohol result of 0.04 or higher, or a refusal. A company hair test produces none of those. The employer cannot report it. The state licensing agency never sees it, plus the CDL stays untouched. That is the law today. It has been the law since the Clearinghouse opened on January 6, 2020.
What a company hair test can cost is the job. An employer may refuse to hire an applicant who fails a company hair test, or fire a driver who fails one, under company policy. That is independent employer authority, separate from Part 382. The distinction confuses drivers who hear that a failed hair test ended a career. It ended a job at one carrier. It did not end the CDL. The driver can apply at the next carrier with a clean Clearinghouse record, as long as no DOT test was failed along the way.
One more protection matters. Under section 382.107, actual knowledge of a driver drug violation bars the employer from using the driver in safety-sensitive work. A positive hair test is not actual knowledge under the current definition, because hair is not a DOT test. That is exactly what H.R. 4320 would change: the bill would add positive hair results from pre-employment plus random tests to the definition, for carriers using vehicles of 10,000 pounds or more. The bill is pending, not law. Until it passes, or HHS issues final hair guidelines, a hair result stays outside the federal system. Drivers who do face a Clearinghouse entry from a DOT test can check the timeline in the Clearinghouse Downgrade Checker, plus track the queries an employer must run in the Clearinghouse Query Tracker.
Why is hair testing still not DOT approved after the FAST Act?
Congress told HHS to write the guidelines a decade ago. The FAST Act of 2015, signed December 4, 2015, directed the Secretary of Health and Human Services to issue scientific and technical guidelines for hair testing within one year, by December 4, 2016. The deadline passed without guidelines. HHS published a notice of proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs using Hair on September 10, 2020, at 85 FR 56108. Six years after that proposal, the guidelines are still not final.
The science is the stated reason. Hair testing raises questions urine testing does not. Drugs can enter hair from the outside, through smoke or dust, which raises the external contamination problem. Hair color, texture, plus cosmetic treatment change how much drug ends up in the hair. Dose, length of exposure, plus the physical and chemical properties of the hair all matter. HHS must settle those questions with cutoffs plus procedures that survive a court challenge, because a federal drug test result can end a career. The agency has not settled them yet.
The latest word from HHS points to more waiting, not less. In its April 1, 2026 report to Congress on the status of the hair testing guidelines, SAMHSA said it plans to issue a new proposed guideline, rather than a final one, to take further public comment on the unresolved scientific issues. A new proposal means a new comment period, then a final guideline at some later date, then a separate DOT rulemaking to add hair to Part 40, because DOT cannot authorize a specimen HHS has not standardized. Each step takes months at best. FMCSA said as much when it denied the Trucking Alliance request to accept hair results in December 2022: the agency lacks the statutory authority until HHS issues final guidelines.
Congress keeps trying to speed the process. H.R. 4320, introduced July 10, 2025, would require carriers to report positive hair results to the Clearinghouse without waiting for HHS guidelines, using FDA-approved hair test devices plus laboratories accredited for forensic hair testing. The bill was referred to the Subcommittee on Highways and Transit on July 11, 2025. It has had no action since. A 2026 House highway reauthorization proposal repeats the FAST Act language, telling DOT to move within one year of receiving HHS guidance, but sets no deadline for HHS to issue it. Until one of these paths produces a final rule, hair testing stays a company policy tool, not a DOT method.
Are instant or point-of-collection tests DOT approved?
No. Section 40.210 names point-of-collection urine testing, point-of-collection oral fluid testing, plus instant tests as not authorized. The reason is structural. A DOT drug test is a chain: collection under Part 40 procedures, screening plus confirmation at an HHS-certified laboratory, then verification by a medical review officer. An instant test breaks every link in that chain. It is read at the collection site by the collector, with no laboratory, no confirmation, plus no MRO. A result from a cup or a dipstick cannot support a Part 382 action, a Clearinghouse report, or a SAP referral.
The trap is speed. An instant cup gives a result in minutes, while a laboratory result takes days. A small carrier that needs a driver on the road today may be tempted to treat the cup as the test. That temptation costs more than it saves. If the carrier acts on the instant result alone, the action has no DOT basis. If the carrier skips the laboratory test, the DOT test reason goes unsatisfied, which is a program violation an auditor finds easily. The FMCSA Fine Calculator shows what program failures cost when an audit finds them.
Instant tests still have a legitimate use, outside DOT. As a company screen, an instant cup can flag a specimen for laboratory confirmation, or clear a driver quickly when the screen is negative. The rule for company use is simple: confirm any positive at a laboratory before acting on it. Never describe the screen as a DOT test. A driver who is asked to take an instant test should ask the same question as for hair: is this a DOT test or a company screen? If it is meant to be a DOT test, it is the wrong test.
Is blood testing used for DOT drug tests?
No. Blood is not a DOT drug test specimen. Section 40.210 authorizes only urine plus oral fluid specimens. Part 40 contains no blood drug test procedure, no blood cutoff table, plus no provision for an HHS-certified blood laboratory. A blood draw ordered as a DOT drug test is a test the regulation does not recognize, whatever the laboratory reports.
Drivers do sometimes see a blood draw after a crash, which causes confusion. A hospital may draw blood for medical treatment, or law enforcement may draw blood under state law after a serious crash. Neither is a DOT drug test. The DOT post-accident drug test is still a urine test, administered within 32 hours of the accident under section 382.303. A medical or law enforcement blood result does not satisfy it. The employer must still order the urine test. The Post-Accident Testing Decision Tool works out whether a crash triggers testing plus which clocks apply.
How do the detection windows compare?
Each specimen answers a different question about time. Blood shows what is in the body right now, within hours. Oral fluid shows recent use, within hours to about 1 to 2 days. Urine shows use over days, longer for marijuana with frequent use. Hair shows a pattern over months, but misses the last 5 to 7 days entirely, because drugs take that long to appear in new hair growth. No single window is best. The right specimen depends on the question the test is meant to answer.
The windows below are approximate industry figures, not regulatory figures. Part 40 sets no detection window for any specimen. The actual window varies by drug, dose, frequency of use, plus the individual. A heavy marijuana user can test positive on urine weeks after last use, while a single use of cocaine may clear in days. Treat every window as a rough guide, never as a promise.
| Specimen | Approximate window | What it catches |
|---|---|---|
| Blood | Hours | Current impairment, very recent use. |
| Oral fluid | Hours to 1 to 2 days | Recent use, hard to cheat. |
| Urine | Days | Use over the past days, the DOT standard. |
| Hair | About 90 days per 1.5 inches | A pattern of use over months, not recent use. |
The 90-day hair figure deserves a note. It is the figure the hair testing industry cites for 1.5 inches of head hair, at an average growth rate of about half an inch per month. The federal draft guidelines proposed something narrower: 0.5 to 1.0 inch of hair, representing about 30 to 60 days. Until HHS issues final guidelines, there is no federal hair window at all, only industry figures plus the draft proposal. Any vendor that quotes a precise hair window as a federal standard is overstating the case.
How do you use the DOT Drug Test Method Checker?
Work through the fields in order. The tool updates with every change, so you can fix an answer and watch the verdict change.
- Pick the test method you were offered or plan to order.
- Say whether you are a driver or an employer.
- Pick the test reason, or company policy test if it is not a DOT test.
- Tick the box if someone told you the method is DOT approved.
- Read the verdict, the checks, plus the method facts.
- Copy the summary for the file or the conversation with the collector.
Use the tool before the collection, not after. A driver who checks the method at the hiring office can ask the right question before the sample is taken. An employer who checks before ordering can avoid paying for a test that cannot satisfy the DOT reason. Copy the summary while the details are fresh: it carries the verdict, the checks, plus the actions in one block of text.
Questions drivers ask
Is hair follicle testing DOT approved?
No. Section 40.210 of 49 CFR Part 40 says hair testing is not authorized for DOT drug tests. Only urine and oral fluid specimens screened and confirmed at HHS-certified laboratories are allowed. A hair test cannot satisfy a DOT drug test. A positive hair result cannot be reported to the Drug and Alcohol Clearinghouse.
Can DOT use oral fluid testing now?
Not yet. DOT authorized oral fluid testing on June 1, 2023, but section 40.67(g)(5) requires at least two HHS-certified oral fluid laboratories before any employer may use it. As of November 2, 2026, zero laboratories are certified. Urine is the only method that works for a DOT drug test today.
What happens if my employer only does a hair test?
The DOT test still has to happen. A hair test alone leaves the DOT test reason unsatisfied, whether it is pre-employment, random, post-accident, or reasonable suspicion. The employer must still order a laboratory urine test. A driver who refuses the urine test because a hair test was already done has refused a DOT test.
Can a positive hair test go on my Clearinghouse record?
No. Only verified positive DOT urine results, alcohol results of 0.04 or higher, plus refusals go to the Drug and Alcohol Clearinghouse. A positive hair test is a company policy result, not a DOT result, so it cannot be reported. A bill in the House, H.R. 4320, would require reporting of positive hair results, but it is pending legislation, not law.
Is an instant drug test valid for DOT?
No. Section 40.210 says point-of-collection urine testing, point-of-collection oral fluid testing, plus instant tests are not authorized. A DOT drug test must be screened and confirmed at an HHS-certified laboratory, with a medical review officer verifying the result. An instant cup or dipstick result is not a DOT result.
What drug test does DOT use?
DOT uses a laboratory urine test that screens for five drug classes: marijuana metabolites, cocaine metabolites, amphetamines, opioids, plus phencyclidine, known as PCP. Oral fluid is authorized as an alternative, but no HHS-certified oral fluid laboratory exists yet, so urine is the only method in use today.
Related tools
- DOT Drug Test Rights Checker: know your rights at the collection, including the split specimen, the shy bladder procedure, plus what counts as a refusal.
- Pre-Employment Hiring Compliance Checker: check the queries plus the steps that must happen before a new driver starts safety-sensitive work.
- Reasonable Suspicion Testing Checker: check whether a reasonable suspicion test is justified, which test to order, plus every deadline.
- Post-Accident Testing Decision Tool: work out whether a crash triggers testing under 49 CFR 382.303, with the 2-hour, 8-hour, plus 32-hour clocks.
- Clearinghouse Downgrade Checker: check the CDL downgrade timeline after a Clearinghouse violation, plus what lifts it.
- DOT Record Retention Checker: work out how long to keep every drug and alcohol testing record, from 1 year to 5 years.
Sources
- 49 CFR 40.210, What kinds of drug tests are permitted (eCFR, read verbatim Nov 19, 2026; govinfo CFR 10-1-25 edition plus DOT ODAPC page)
- 49 CFR 40.67, When and how is a directly observed urine collection conducted (eCFR; paragraphs (g)(3)-(6) read verbatim from the final rule, 91 FR 25507)
- 49 CFR 40.82, What drugs do laboratories test for (eCFR, read verbatim Nov 19, 2026)
- 49 CFR 40.85, What are the cutoff concentrations for urine drug tests (eCFR, read verbatim Nov 19, 2026)
- 49 CFR 40.193, What happens when an employee does not provide a sufficient amount of specimen (eCFR; read verbatim from the DOT ODAPC page, Nov 19, 2026)
- Procedures for Transportation Workplace Drug and Alcohol Testing Programs, final rule, 91 FR 25507 (FR Doc. 2026-09290, May 11, 2026, effective June 10, 2026)
- Current List of HHS-Certified Laboratories, FR Doc. 2026-22321 (Federal Register, November 2, 2026: zero oral fluid laboratories certified)
- SAMHSA Certified Laboratory List (HHS, monthly list; October 2026 listing checked Nov 19, 2026)
- HHS Certified Oral Fluid Laboratories (DOT ODAPC, read Nov 19, 2026: no certified laboratories)
- H.R. 4320, Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025 (introduced July 10, 2025; referred to the Subcommittee on Highways and Transit July 11, 2025; no further action)
- HHS Report to Congress on the Status of the Hair Testing Guidelines (April 1, 2026: SAMHSA plans a new proposed guideline, not a final one)
- Overview of Drug and Alcohol Rules (FMCSA, read Nov 19, 2026)
- HHS, Proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid, 91 FR 68364, FR Doc. 2026-22121 (October 29, 2026; comments due December 28, 2026)